High plasma soluble CD163 during infancy is a marker for neurocognitive outcomes in early-treated HIV-infected children
Journal of Acquired Immune Deficiency Syndromes | Apr 14, 2019
Most read this week
Journal of Acquired Immune Deficiency Syndromes | Apr 14, 2019